- Report
- May 2025
- 267 Pages
Global
From €4344EUR$4,950USD£3,759GBP
- Report
- October 2024
- 122 Pages
Global
From €4081EUR$4,650USD£3,531GBP
- Report
- May 2025
- 180 Pages
Global
From €3111EUR$3,545USD£2,692GBP
€3457EUR$3,939USD£2,991GBP
- Report
- March 2025
- 175 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- July 2025
- 282 Pages
Global
From €5134EUR$5,850USD£4,442GBP
- Report
- July 2025
- 220 Pages
Global
From €5134EUR$5,850USD£4,442GBP
- Report
- February 2025
- 180 Pages
Global
From €3357EUR$3,825USD£2,905GBP
€3949EUR$4,500USD£3,417GBP
- Report
- May 2025
- 114 Pages
Global
From €4169EUR$4,750USD£3,607GBP
- Report
- July 2025
- 421 Pages
Global
From €6139EUR$6,995USD£5,312GBP
- Report
- August 2024
- 180 Pages
Global
From €2106EUR$2,400USD£1,822GBP
- Report
- May 2025
- 183 Pages
Global
From €3111EUR$3,545USD£2,692GBP
€3457EUR$3,939USD£2,991GBP
- Report
- May 2025
- 100 Pages
Global
From €5222EUR$5,950USD£4,518GBP
- Report
- November 2024
- 120 Pages
Global
From €5222EUR$5,950USD£4,518GBP
- Report
- April 2025
- 175 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- March 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- November 2024
- 338 Pages
Global
From €4388EUR$5,000USD£3,797GBP
- Report
- July 2025
- 174 Pages
Global
From €5134EUR$5,850USD£4,442GBP
- Report
- June 2025
- 182 Pages
Global
From €3949EUR$4,500USD£3,417GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1755EUR$2,000USD£1,519GBP
- Report
- May 2025
- 90 Pages
Global
From €3500EUR$4,272USD£3,134GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more